June 11 Visit us at Biomarker & Immuno-oncology World Congress 2018

2018-06-05

The 2018 Biomarker & Immuno-oncology World Congress in Boston brings together biopharma, molecular diagnostics companies and research institutes to discuss the development of biomarkers for immunotherapy. On June 11th, Dr. Kien Thiam Tan will present our newly developed TME (tumor microenvironment) profiling service, aimed to identify patients suitable for immune checkpoint inhibitors. Visit us at booth #2 to find out how our TME profiling service and ACTOnco® comprehensive genomic profiling can accelerate cancer drug development!     http://www.biomarkerworldcongress.com/

Image title